Filed 1.1y ago· Apr 11, 2025
32 days to disclose
Carol D. Miller
RHouseWest Virginia-01
↓sold
Pfizer
PFE
$1K-$15K
+0.6% vs S&P 500
Trade dateMar 10, 2025
Pfizer, Inc.
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–7 of 7
Filed 1.1y ago· Apr 11, 2025
32 days to discloseCarol D. Miller
RHouseWest Virginia-01
↑bought
Gilead Sciences
GILD
$1K-$15K
+14.7% vs S&P 500
Trade dateMar 10, 2025
⚑ Pharmaceutical
Filed 3.8y ago· Sep 2, 2022
296 days to disclose · 251 past 45-day windowCarol D. Miller
RHouseWest Virginia-01
↓sold
Johnson & Johnson
JNJ
$15K-$30K
+15.5% vs S&P 500
Trade dateNov 10, 2021
⚑ Pharmaceutical
Filed 3.8y ago· Sep 2, 2022
296 days to disclose · 251 past 45-day windowCarol D. Miller
RHouseWest Virginia-01
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
+55.1% vs S&P 500
Trade dateNov 10, 2021
⚑ Pharmaceutical
Filed 3.8y ago· Sep 2, 2022
401 days to disclose · 356 past 45-day windowCarol D. Miller
RHouseWest Virginia-01
↓sold
Merck
MRK
$15K-$50K
+19.8% vs S&P 500
Trade dateJul 28, 2021
Stock
⚑ Pharmaceutical
Filed 3.8y ago· Sep 2, 2022
401 days to disclose · 356 past 45-day windowCarol D. Miller
RHouseWest Virginia-01
↑bought
Amgen
AMGN
$15K-$50K
−21.6% vs S&P 500
Trade dateJul 28, 2021
⚑ Pharmaceutical
Filed 3.8y ago· Sep 2, 2022
401 days to disclose · 356 past 45-day windowCarol D. Miller
RHouseWest Virginia-01
↓sold
Gilead Sciences
GILD
$15K-$30K
−23.4% vs S&P 500
Trade dateJul 28, 2021
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 11, 2025 1.1y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Pfizer PFE Pfizer, Inc. ⚑ Pharmaceutical · Ways and Means | Mar 10, 2025 32 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Carol D. Miller RHouseWest Virginia-01 | ↑bought | Gilead Sciences GILD ⚑ Pharmaceutical · Ways and Means | Mar 10, 2025 32 days to disclose | Good buy·+$1.2K+15.3% +14.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Nov 10, 2021 296 days to disclose · 251 past 45-day window | Missed gain·−$8.7K-38.5% +15.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Nov 10, 2021 296 days to disclose · 251 past 45-day window | Smart sell·+$372+1.1% +55.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Jul 28, 2021 401 days to disclose · 356 past 45-day window | Missed gain·−$13.9K-42.9% +19.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↑bought | Amgen AMGN ⚑ Pharmaceutical · Ways and Means | Jul 28, 2021 401 days to disclose · 356 past 45-day window | Good buy·+$13.3K+41.1% −21.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Gilead Sciences GILD ⚑ Pharmaceutical · Ways and Means | Jul 28, 2021 401 days to disclose · 356 past 45-day window | Missed gain·−$19.4K-86.1% −23.4% vs S&P 500 | $15K-$30K midpoint $22.5K |